Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study

Stopped early · Phase 2

Conditions studied: Endometriosis

In brief

ZPE-201 Extension of treatment

Key facts

Study ID

NCT00958412

Run by

Repros Therapeutics Inc.

People needed

18

Starts

2009-02-28

Expected to finish

2009-08-31

Last updated by the study team

2019-02-12

Who can join

Age: 18 and older, up to 48. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Only subjects treated in the ZPE-201 study will be allowed to enter the extension study.
• Subjects who withdrew from ZPE-201 due to lack of treatment efficacy will also be invited to participate.

You may not qualify if…

• All other subjects

Where it is running

• Advanced Clinical Therapeutics, LLC — Tucson, Arizona, United States
• Medical Center for Clinical Research — San Diego, California, United States
• Compass Clinical Research — San Ramon, California, United States
• Comprehensive Clinical Trials — West Palm Beach, Florida, United States
• Physicians for Women — Cary, North Carolina, United States
• HWC Women's Research Center — Miamisburg, Ohio, United States
• Clinical Trials of Texas/Institute for Women's Health — San Antonio, Texas, United States
• Clinical Trials of Texas/Seven Oaks Women's Center — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.